Genetic Technology--Innovations across Gene Therapy, Infectious Diseases, and Neurodegenerative Diseases

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue depicts the current landscape and the new trends in a series of developments associated with gene therapy and neurodegenerative diseases. The first part of the study focuses on research collaborations between innovative pharmaceutical companies, whereas the second part is mostly centered on innovation and technology management. An appendix is included, comprising lists of most notable patents related to the treating of rare diseases.

Keywords: gene therapy, adeno-associated virus , neurodegenerative disorders, Alzheimer’s disease, epilepsy, neuropathic pain, malignant melanoma, prostate cancer, pancreatic cancer, X-linked retinoscheis retinitis pigmentosa, achromatopsia, wet age-related macular degeneration, influenza A, Alpha1-antitrypsin deficiency, hereditary angioedema, allergy

Table of Contents

Genetic Technology--Innovations across Gene Therapy, Infectious Diseases, and Neurodegenerative DiseasesResearch Collaborations for Gene TherapyAGTC and Synpromics Collaborate for Developing Gene Therapies for Eye Diseases Annapurna Therapeutics and Weil Cornell Collaborate for Developing Gene TherapiesInnovations in Infectious and Neurodegenerative DiseasesScientists Identify a Role for Host Ligase in the Pathogenesis of Influenza ABiopharmaceutical Company Actively Involves in Solving Growing Threat of Alzheimer’s Disease AppendixPatent AnalysisPatent Analysis (continued)Industry Interactions




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.